Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761

Journal of Alzheimer's Disease

Volumn 5, Issue 4, 2003, Pages 287-300

  Vining Smith, Julie ^a   Luo, Yuan ^a  

^a The University of Southern Mississippi   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Caenorhabditis elegans; Ginkgo biloba; Reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; GINKGO BILOBA EXTRACT; HYDROGEN PEROXIDE; KAEMPFEROL; QUERCETIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; GINKGO BILOBA; IN VITRO STUDY; IN VIVO STUDY; MUTATION; NEUROBLASTOMA; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; TRANSGENIC ANIMAL;

EID: 0242467845     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2003-5404     Document Type: Article

References (73)

1. H. Adachi and N. Ishii, Effects of tocotrienols on life span and protein carbonylation in Caenorhabditis elegans, J Gerontol A Biol Sci Med Sci 55 (2000), B280-285.
2. K. Andersen, L.J. Launer, A. Ott, A.W. Hoes, M.M. Breteler and A. Hofman, Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study Neurology 45 (1995), 1441-1445.
3. S. Aydin, R. Ozaras, H. Uzun, A. Belce, E. Uslu, V. Tahan, T. Altug, E. Dumen and H. Senturk, N-acetylcysteine reduced the effect of ethanol on antioxidant system in rat plasma and brain tissue, Tohoku J Exp Med 198 (2002), 71-77.
4. S.W. Barger, D. Horster, K. Furukawa, Y. Goodman, J. Krieglstein and M.P. Mattson, Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation, Proc Natl Acad Sci USA 92 (1995), 9328-9332.
5. S. Bastianetto, C. Ramassamy, S. Dore, Y. Christen, J. Poirier and R. Quirion, The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid, Eur J Neurosci 12 (2000), 1882-1890.
6. C. Behl, J. Davis, G.M. Cole and D. Schubert, Vitamin E protects nerve cells from amyloid beta protein toxicity, Biochem Biophys Res Commun 186 (1992), 944-950.
7. C. Behl, J.B. Davis, R. Lesley and D. Schubert, Hydrogen peroxide mediates amyloid beta protein toxicity, Cell 77 (1994), 817-827.
8. H.K. Biesalski, Free radical theory of aging, Curr Opin Clin Nutr Metab Care 5 (2002), 5-10.
9. D.A. Butterfield, B. Howard, S. Yatin, T. Koppal, J. Drake, K. Hensley, M. Aksenov, M. Aksenova, R. Subramaniam, S. Varadarajan, M.E. Harris-White, N.W. Pedigo, Jr. and J.M. Camey, Elevated oxidative stress in models of normal brain aging and Alzheimer's disease, Life Sci 65 (1999), 1883-1892.
10. D.A. Butterfield, B.J. Howard, S. Yatin, K.L. Allen and J.M. Camey, Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone, Proc Natl Acad Sci USA 94 (1997), 674-678.
11. D.A. Butterfield, T. Koppal, B. Howard, R. Subramaniam, N. Hall, K. Hensley, S. Yatin, K. Allen, M. Aksenov, M. Aksenova and J. Camey, Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E, Ann N Y Acad Sci 854 (1998), 448-462.
12. D.A. Butterfield, T. Koppal, R. Subramaniam and S. Yatin, Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease, Rev Neurosci 10 (1999), 141-149.
13. D. A. Butterfield, S.M. Yatin and C.D. Link, In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid beta-peptide (1-42), Ann N Y Acad Sci 893 (1999), 265-268.
14. D.A. Butterfield, S.M. Yatin, S. Varadarajan and T. Koppal, Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease, Methods Enzymol 309 (1999), 746-768.
15. C.K. Chow, W. Ibrahim, Z. Wei and A.C. Chan, Vitamin E regulates mitochondrial hydrogen peroxide generation, Free Radic Biol Med 27 (1999), 580-587.
16. Y. Christen, Oxidative stress and Alzheimer disease, Am J Clin Nutr 71 (2000), 621S-629S.
17. Y. Christen, M.T. Droy-Lefaix, C. Pasquier and L. Packer, Effects of Ginkgo biloba extract (EGb761) on Alzheimer's Disease, in: Free Radicals in Brain Pathophysiology, L. Packer, ed., Marcel Decker, Inc.: New York, 2000, pp. 411-425.
18. Y. Christen and J.M. Maixent, What is Ginkgo biloba extract EGb 761? An overview - from molecular biology to clinical medicine, Cell Mol Biol (Noisy-le-grand) 48 (2002), 601-611.
19. F.V. Defeudis, Bilobalide and Neuroprotection, Pharmacol Res 46 (2002), 565-568.
20. F.V. DeFeudis, Ginkgo biloba extract (EGb 76]): from chemistry to clinic, Publi Ullstein Med. Weisbaden, Germany, 1998.
21. F.V. DeFeudis and K. Drieu, Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications, Curr Drug Targets 1 (2000), 25-58.
22. J. Drake, C.D. Link and D.A. Butterfield, Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model, Neurobiol Aging 24 (2003), 415-420.
23. M. Ganzera, J. Zhao and I.A. Khan, Analysis of terpenelactones in Ginkgo biloba by high performance liquid chromatography and evaporative light scattering detection, Chem Pharm Bull (Tokyo) 49 (2001), 1170-1173.
24. S. Goto, Biological implications of protein oxidation, Critical Reviews of Oxidative Stress and Aging. Advances in Basic Science, Diagnostics and Intervention, ed. Rodriguez., R.C.a.H. Vol. Vol 1, New Jersey: World Scientific Publishing. Chapter 20, 2003, pp. 350-365.
25. S. Goto, A. Nakamura, Z. Radak, H. Nakamoto, R. Takahashi, K. Yasuda, Y. Sakurai and N. Ishii, Carbonylated proteins in aging and exercise: immunoblot approaches, Mech Ageing Dev 107 (1999), 245-253.
26. D. Harman, Ageing: a theory based on free radical and radiation chemistry, J Gerontol 2 (1957), 298-300.
27. A. Hasler, Chemical constituts of Ginkgo biloba, in: Ginkgo biloba Harwood Academic Publishers, T. van Beek, ed., Amsterdam, 2000, pp. 109-142.
28. A. Hasler, G.A. Gross, B. Meier and O. Sticher, Complex flavonol glycosides from the leaves of Ginkgo biloba, Phytochemistry 31 (1992), 1391-1394.
29. H.M. Hassan and I. Fridovich, Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds, Arch Biochem Biophys 196 (1979), 385-395.
30. K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R.L. Russell, C.S. Atwood, A.B. Johnson, Y. Kress, H.V. Vinters, M. Tabaton, S. Shimohama, A.D. Cash, S.L. Siedlak, P.L. Harris, P.K. Jones, R.B. Petersen, G. Perry and M.A. Smith, Mitochondrial abnormalities in Alzheimer's disease, J Neurosci 21 (2001), 3017-3023.
31. Y. Honda and S. Honda, Oxidative stress and life span determination in the nematode Caenorhabditis elegans, Ann N Y Acad Sci 959 (2002), 466-474.
32. M. Hull, B.L. Fiebich, G. Schumann, K. Lieb and J. Bauer, Anti-inflammatory substances - a new therapeutic option in Alzheimer's disease, Drug Discov Today 4 (1999), 275-282.
33. A. Kontush, Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease, Free Radic Biol Med 31 (2001), 1120-1131.
34. P.L. Le Bars, M.M. Katz, N. Berman, T.M. Itil, A.M. Freedman and A.F. Schatzberg, A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia, North American EGb Study Group Jama 278 (1997), 1327-1332.
35. P.L. Le Bars, M. Kieser and K.Z. Itil, A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia, Dement Geriatr Cogn Disord 11 (2000), 230-237.
36. E.J. Lien, S. Ren, H.H. Bui and R. Wang, Quantitative structure-activity relationship analysis of phenolic antioxidants, Free Radic Biol Med 26 (1999), 285-294.
37. C.D. Link, Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans, Proc Natl Acad Sci USA 92 (1995), 9368-9372.
38. C.D. Link, Transgenic invertebrate models of age-associated neurodegenerative diseases, Mech Ageing Dev 122 (2001), 1639-1649.
39. Y. Luo, Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease, J Alzheimers Dis 3 (2001), 401-407.
40. Y. Luo, J.V. Smith, V. Paramasivam, A. Burdick, K.J. Curry, J.P. Buford, I. Khan, W.J. Netzer, H. Xu and P. Butko, Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761, Proc Natl Acad Sci USA 99 (2002), 12197-12202.
41. I. Maitra, L. Marcocci, M.T. Droy-Lefaix and L. Packer, Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761, Biochem Pharmacol 49 (1995), 1649-1655.
42. M. Marquez, C.E. Yepez, R. Sutil-Naranjo and M. Rincon, [Basic aspects and measurement of the antioxidant vitamins A and E], Invest Clin 43 (2002), 191-204.
43. M.P. Mattson, Risk Factors and Mechanisms of Alzheimer's Disease Pathogenesis: Obviously and Obviously Not, J Alzheimers Dis 2 (2000), 109-112.
44. S. Melov, J. Ravenscroft, S. Malik, M.S. Gill, D.W. Walker, P.E. Clayton, D.C. Wallace, B. Malfroy, S.R. Doctrow and G.J. Lithgow, Extension of life-span with superoxide dismutase/catalase mimetics, Science 289 (2000), 1567-1569.
45. K.H. Miean and S. Mohamed, Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants, J Agric Food Chem 49 (2001), 3106-3112.
46. W.C. Orr and R.S. Sohal, Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster, Science 263 (1994), 1128-1130.
47. L. Packer and C. Colman, The Antioxidant Miracle, L. Packer and C. Colman, New York: John Wiley & Sons, Inc., 1999, pp. 256.
48. G. Perry, R.J. Castellani, K. Hirai and M.A. Smith, Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease, J Alzheimers Dis 1 (1998), 45-55.
49. G. Perry, A.K. Raina, A. Nunomura, T. Wataya, L.M. Sayre and M.A. Smith, How important is oxidative damage? Lessons from Alzheimer's disease, Free Radic Biol Med 28 (2000), 831-834.
50. S.S. Pitchumoni and P.M. Doraiswamy, Current status of antioxidant therapy for Alzheimer's Disease, J Am Geriatr Soc 46 (1998), 1566-1572.
51. 2 in cultured endothelial cells, Arch Biochem Biophys 302 (1993), 348-355.
52. J. Sastre, A. Lloret, C. Borras, J. Pereda, D. Garcia-Sala, M.T. Droy-Lefaix, F.V. Pallardo and J. Vina, Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the brain and in the liver, Cell Mol Biol (Noisy-le-grand) 48 (2002), 685-692.
53. D. Schubert, C. Behl, R. Lesley, A. Brack, R. Dargusch, Y. Sagara and H. Kimura, Amyloid peptides are toxic via a common oxidative mechanism, Proc Natl Acad Sci USA 92 (1995), 1989-1993.
54. D.J. Selkoe, Alzheimer's disease: genes, proteins, and therapy, Physiol Rev 81 (2001), 741-766.
55. N. Senoo-Matsuda, K. Yasuda, M. Tsuda, T. Ohkubo, S. Yoshimura, H. Nakazawa, P.S. Hartman and N. Ishii, A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans, J Biol Chem 276 (2001), 41553-41558.
56. J.V. Smith, A.J. Burdick, P. Golik, I. Khan, D. Wallace and Y. Luo, Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells, Cell Mol Biol (Noisy-le-grand) 48 (2002), 699-707.
57. M.A. Smith and G. Perry, Molecular and cellular aspects of oxidative damage in Alzheimer's disease, Free Radicals in Brain Pathophysiology, ed. Marcel Dekker, I. 2000, Torino: G. Poli. Ch 15, pp. 313-321.
58. P.F. Smith, K. Maclennan and C.L. Darlington, The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF), J Ethnopharmacol 50 (1996), 131-139.
59. Y.J. Suzuki, M. Tsuchiya and L. Packer, Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species, Free Radic Res Commun 15 (1991), 255-263.
60. G. Thinakaran, D.B. Teplow, R. Siman, B. Greenberg and S.S. Sisodia, Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus, J Biol Chem 271 (1996), 9390-9397.
61. D.C. Wallace and S. Melov, Radicals r'aging, Nat Genet 19 (1998), 105-106.
62. S. Weggen, J.L. Eriksen, P. Das, S.A. Sagi, R. Wang, C.U. Pietrzik, K.A. Findlay, T.E. Smith, M.P. Murphy, T. Bulter, D.E. Kang, N. Marquez-Sterling, T.E. Golde and E.H. Koo, A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity, Nature 414 (2001), 212-216.
63. T. Wei, Y. Ni, J. Hou, C. Chen, B. Zhao and W. Xin, Hydrogen peroxide-induced oxidative damage and apoptosis in cerebellar granule cells: protection by Ginkgo biloba extract, Pharmacol Res 41 (2000), 427-433.
64. A.P. Wickens, Ageing and the free radical theory, Respir Physiol 128 (2001), 379-391.
65. S. Wirth, J. Stemmelin, B. Will, Y. Christen and G. Di Scala, Facilitative effects of EGb 761 on olfactory recognition in young and aged rats, Pharmacol Biochem Behav 65 (2000), 321-326.
66. Z. Wu, J.V. Smith, V. Paramasivam, P. Butko, I. Khan, J.R. Cypser and Y. Luo, Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of caenoraibditis elegans, Cell Mol Biol (Noisy-le-grand) 48 (2002), 725-731.
67. H. Xu, D. Sweeney, R. Wang, G. Thinakaran, A.C. Lo, S.S. Sisodia, P. Greengard and S. Gandy, Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation, Proc Natl Acad Sci USA 94 (1997), 3748-3752.
68. Z.X. Yao, K. Drieu, L.I. Szweda and V. Papadopoulos, Free radicals and lipid peroxidation do not mediate beta-amyloid-induced neuronal cell death, Brain Res 847 (1999), 203-210.
69. S.M. Yatin, S. Varadarajan and D.A. Butterfield, Vitamin E Prevents Alzheimer's Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production, J Alzheimers Dis 2 (2000), 123-131.
70. S.M. Yatin, S. Varadarajan, C.D. Link and D.A. Butterfield, In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42), Neurobiol Aging 20 (1999), 325-330; discussion 339-342.
71. S.M. Yatin, M. Yatin, T. Aulick, K.B. Ain and D.A. Butterfield, Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E, Neurosci Lett 263 (1999), 17-20.
72. L.J. Zhou and X.Z. Zhu, Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide, J Pharmacol Exp Ther 293 (2000), 982-988.
73. M. Zimmermann, F. Colciaghi, F. Cattabeni and M. Di Luca, Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease, Cell Mol Biol (Noisy-le-grand) 48 (2002), 613-623.